Search

Your search keyword '"Capello, Daniela"' showing total 260 results

Search Constraints

Start Over You searched for: Author "Capello, Daniela" Remove constraint Author: "Capello, Daniela" Search Limiters Full Text Remove constraint Search Limiters: Full Text
260 results on '"Capello, Daniela"'

Search Results

2. The Mutator Pathway Is a Feature of Immunodeficiency-Related Lymphomas

3. Extracellular vesicles from human plasma for biomarkers discovery: Impact of anticoagulants and isolation techniques

4. Public Attitude towards Biobanking: An Italian University Survey

5. UPO Biobank: The Challenge of Integrating Biobanking into the Academic Environment to Support Translational Research.

6. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

7. Dissecting the Mechanism of Action of Spiperone—A Candidate for Drug Repurposing for Colorectal Cancer

8. The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma

9. Persistence of Neutralizing Antibodies to SARS-CoV-2 in First Wave Infected Individuals at Ten Months Post-Infection: The UnIRSA Cohort Study

12. Identification of Key Phospholipids That Bind and Activate Atypical PKCs

15. Structure activity relationship studies on Amb639752: toward the identification of a common pharmacophoric structure for DGKα inhibitors

19. Hypermethylation of the DNA repair gene [0.sup.6]-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma

23. Structure activity relationship studies on Amb639752: toward the identification of a common pharmacophoric structure for DGKα inhibitors.

24. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia

25. Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma

26. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

27. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma

28. The Diacylglycerol Kinase α/Atypical PKC/β1 Integrin Pathway in SDF-1α Mammary Carcinoma Invasiveness

29. Alternative Translocation Breakpoint Cluster Region 5' to BCL-6 in B-cell Non-Hodgkin’s Lymphoma

31. Mutations of NOTCH1 Are An Independent Predictor of Survival in Chronic Lymphocytic Leukemia

32. Clues to the Pathogenesis of Waldenström Macroglobulinemia and Other Monoclonal IgM Disorders Provided by the Analysis of Immunoglobulin Heavy Chain Gene Rearrangement and Clustering of B-Cell Receptors,

33. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

34. The Genotype of MLH1 Is An Independent Predictor of Outcome In Diffuse Large B-Cell Lymphoma Treated with R-CHOP: a Training-Validation Study

35. Molecular History of Richter Syndrome: Origin From a Common Ancestor Cell Already Present at Chronic Lymphocytic Leukemia Diagnosis

36. IGH Repertoire Analysis In Multiple Myeloma (MM): Lack of Intra-Disease Homology and Occasional Clustering with Sequences of Other B-Cell Neoplasms Sharing Identical Geographical Origin

37. The NF-κB Pathway Is Targeted by Multiple Genetic Lesions In Splenic Marginal Zone Lymphoma

38. Expression of Mutated IGHV3-23 Genes in Chronic Lymphocytic Leukemia Identifies a Disease Subset with Peculiar Clinical and Biological Features

39. SNP-Arrays Provide New Insights Into the Pathogenesis of Post-Transplant Diffuse Large B-Cell Lymphoma (PT-DLBCL).

40. Stereotyped Patterns of HCDR3 Sequences in Splenic Marginal Zone B-Cell Lymphoma (SMZL): SMZL-Biased Subsets Are Associated with a Worse Outcome.

41. Characteristics of the Immunoglobulin Heavy Chain (IgH) Rearrangement in Multiple Myeloma (MM): An Analysis On 308 Cases.

42. Chronic Lymphocytic Leukemia Subset Expressing Mutated IGHV3-23 Has Peculiar Clinical and Biological Features.

44. The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness

46. The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia (CLL) Is Independent of del17p13: Implications for Overall Survival and Chemorefractoriness

47. The Pharmacogenetic Background of the Host Is An Independent Predictor of Outcome and Toxicity in Diffuse Large B Cell Lymphoma Treated with R-CHOP21

48. Telomere Length Is An Independent Predictor of Survival, Treatment Requirement and Richter’s Syndrome Transformation in Chronic Lymphocytic Leukemia.

49. Genome-Wide DNA Profiling Identifies a Stable Profile Although with Aberrations Targeting the Fibroblast Growth Factor Pathway in Hairy Cell Leukemia.

50. Molecular, Phenotypic and Clinical Predictors of Richter Syndrome (RS) in Chronic Lymphocytic Leukemia (CLL).

Catalog

Books, media, physical & digital resources